SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Procter & Gamble Hygiene and Health Care Ltd

BSE: 500459 NSE: PGHH ISIN: INE179A01014
  |   Sector:  FMCG   |   Industry:  Household & Personal Products

Snapshot

Q.1 Which industry/sub-sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd belongs to the FMCG sector, operating specifically within the Household & Personal Products segment.
Q.2 Is Procter & Gamble Hygiene and Health Care Ltd a good quality company?
Procter & Gamble Hygiene and Health Care Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Procter & Gamble Hygiene and Health Care Ltd undervalued or overvalued?
Procter & Gamble Hygiene and Health Care Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Procter & Gamble Hygiene and Health Care Ltd a good buy now?
Procter & Gamble Hygiene and Health Care Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd revenue growth is 7% for FY-2025 , which is below its 5 year CAGR of 8.4% , indicating slower growth.
Q.2 Gross Profit margin of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Gross profit margin which is the profit after deduction of direct costs, is 21.3% for FY-2025 , which is above its 5 year median of 19.7% , indicating increasing margins.
Q.3 Operating Profit Margin of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 25.91% for FY-2025 , which is above its 5 year median of 22.93% indicating increasing margins.
Q.4 Net Profit Margin of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Net Profit Margin is 18.87% for FY-2025 , is above with its 5 year median of 17.31%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 21.3 19.7
Operating Profit Margin 25.91 22.93
Net Profit Margin 18.87 17.31
Q.5 Return on Asset of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Return on Asset is 36.84%, which is above its 5 year historical median of 36.63%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Return on equity is 90.52% for FY-2025 , which is above its historical median of 83.56%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Return on capital employed is 115.95% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 11.25%, indicating value creation.
Q.8 Cash conversion cycle of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Cash conversion cycle is -83 days, below its historical median of -74 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 2.43 2.52
ROE 90.52 83.56
ROCE 115.95 110.39
Cash Conversion Cycle -83 days -74 days
Q.9 Debt to Equity ratio of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Debt-to-Equity ratio is 0.00 , which is in line with the industry average of 0 , indicating similar to debt levels in the industry.
Q.10 Debt to cash flow from operations of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Procter & Gamble Hygiene and Health Care Ltd?
Promoters hold 70.64% of the Procter & Gamble Hygiene and Health Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Procter & Gamble Hygiene and Health Care Ltd vs industry peers?
Procter & Gamble Hygiene and Health Care Ltd revenue CAGR is 8.43% , compared to the industry median CAGR of 7.66% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 4,499.2 5,226.2
Gross Profit 718.7 1,588.7
Operating Profit 870 1,566
Net Profit 637 1,078
Operating Efficiency
Current Level Industry Median
Asset Turnover 2.43 1
ROE 90.52 74.4
ROCE 115.95 98.37
Cash Conversion Cycle (days) -83.17 -42

Valuation & price assessment

Q.1 Stock return of Procter & Gamble Hygiene and Health Care Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 4.4% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 4.4% -6.4% -10.6% -29.4%
Q.3 Valuation ratios of Procter & Gamble Hygiene and Health Care Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 37.25 76.46 46.15
Price to Book 25.97 29.18 3.35
Price to Sales 7.39 11.03 3.74
EV to EBITDA 25.77 49.72 22.53

Check more companies

1. Dabur India
2. Colgate Palmol. (I)
3. P&G Hygiene
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×